136 related articles for article (PubMed ID: 16490593)
1. Negative implication of C-MYC as an amplification target in esophageal cancer.
Huang XP; Rong TH; Wang JY; Tang YQ; Li BJ; Xu DR; Zhao MQ; Zhang LJ; Fang Y; Su XD; Liang QW
Cancer Genet Cytogenet; 2006 Feb; 165(1):20-4. PubMed ID: 16490593
[TBL] [Abstract][Full Text] [Related]
2. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
3. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.
van Duin M; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Siersema PD; van Dekken H
Cytogenet Genome Res; 2007; 118(2-4):130-7. PubMed ID: 18000363
[TBL] [Abstract][Full Text] [Related]
4. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
5. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
[TBL] [Abstract][Full Text] [Related]
6. c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression.
von Rahden BH; Stein HJ; Pühringer-Oppermann F; Sarbia M
Neoplasia; 2006 Sep; 8(9):702-7. PubMed ID: 16984727
[TBL] [Abstract][Full Text] [Related]
7. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
[TBL] [Abstract][Full Text] [Related]
8. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
10. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.
Augenlicht LH; Wadler S; Corner G; Richards C; Ryan L; Multani AS; Pathak S; Benson A; Haller D; Heerdt BG
Cancer Res; 1997 May; 57(9):1769-75. PubMed ID: 9135021
[TBL] [Abstract][Full Text] [Related]
11. Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies.
Storlazzi CT; Fioretos T; Paulsson K; Strömbeck B; Lassen C; Ahlgren T; Juliusson G; Mitelman F; Rocchi M; Johansson B
Hum Mol Genet; 2004 Jul; 13(14):1479-85. PubMed ID: 15163636
[TBL] [Abstract][Full Text] [Related]
12. Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.
Rao JY; Apple SK; Jin Y; Lin S; Nieberg RK; Hirtschowitz SL
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):175-9. PubMed ID: 10698478
[TBL] [Abstract][Full Text] [Related]
13. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.
Ferber MJ; Eilers P; Schuuring E; Fenton JA; Fleuren GJ; Kenter G; Szuhai K; Smith DI; Raap AK; Brink AA
Cancer Genet Cytogenet; 2004 Oct; 154(1):1-9. PubMed ID: 15381365
[TBL] [Abstract][Full Text] [Related]
14. Frequent upregulation of MYC in plasma cell leukemia.
Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of c-myc gene in esophageal squamous cell carcinoma].
He J; Zhang RG; Zhu D
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):94-6, 127. PubMed ID: 7767777
[TBL] [Abstract][Full Text] [Related]
16. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
[TBL] [Abstract][Full Text] [Related]
17. A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1.
Dvorácková J; Uvírová M
Neoplasma; 2007; 54(2):149-54. PubMed ID: 17319789
[TBL] [Abstract][Full Text] [Related]
18. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.
Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR
Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 overexpression in esophageal cancer from southern China and its clinical significance.
Xiao-Ping H; Tie-Hua R; Peng L; Qiu-Liang W; Guang-Yu Y; Jing-Hui H; Xiao-Dong S; Xiao-Dong L; Bao-Jiang L; Peng-Yuan Z; Kai L; Zhi-Fan H
Cancer Lett; 2006 Jan; 231(1):94-101. PubMed ID: 16051426
[TBL] [Abstract][Full Text] [Related]
20. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
